Quantcast
Last updated on April 19, 2014 at 8:45 EDT

Latest Personalized medicine Stories

2013-09-03 23:23:45

CDER to Use Entelos Software to Explore Mechanisms of Drug-Induced Liver Injury San Mateo, CA (PRWEB) September 03, 2013 Entelos, a provider of in silico modeling and simulation products and consulting services, today announced a licensing agreement with the US Food and Drug Administration (FDA) for use of the PhysioLab Modeler software in its drug safety research. The license provides FDA with access to a computer model of drug-induced liver injury (DILI) that was developed under a 5...

2013-09-03 10:13:25

The mitochondria are the powerhouses of the cell, converting energy into usable forms. When a child is born with a gene defect that results in dysfunctional mitochondria, the results can be devastating, causing physical and cognitive disability and often death. Using genome-wide sequencing along with personalized functional genomics, researchers led by those at Baylor College of Medicine have identified mutations in a gene called FBXL4 revealing it as a novel cause of primary mitochondrial...

2013-08-29 12:25:40

ALBANY, New York, August 29, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global companion diagnostics market was valued at USD 1.8 billion in 2012 and is expected to grow at a CAGR...

2013-08-22 08:26:42

Expansion offers key international markets innovative, thorough biomarker analysis to improve care for cancer patients IRVING, Texas, Aug. 22, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence(TM), in select Middle Eastern and African markets. Given...

2013-08-21 08:25:37

ALBANY, New York, August 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global molecular cytogenetics market was valued at USD 469.2 million in 2012 and is estimated to...

2013-08-19 23:04:45

Bina Accelerates Fast and Accurate Genomic Interpretation at a Fraction of the Cost of Whole Genome Analysis Redwood City, CA (PRWEB) August 19, 2013 Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced the launch of its Whole Exome application and Bina On-Demand offering, the latest additions to the company’s fully integrated Bina Genomic Analysis Platform, which performs whole genome analysis in 4 hours or less. Exome sequencing...

Twenty Percent Women Don't Believe Breast Cancer Risk
2013-08-16 08:52:41

April Flowers for redOrbit.com - Your Universe Online A new study led by researchers at the University of Michigan Comprehensive Cancer Center reveals nearly 20 percent of women do not believe their breast cancer risk despite using a tailored risk assessment tool that factors in family history and personal habits. The findings, published in the journal Patient Education and Counseling, were compiled during a larger study looking at how to improve patients’ understanding of risk...

2013-08-13 04:20:43

Thomson Reuters, PathGroup and GenoSpace collaborate to deliver advanced personalized medicine assays and reports to oncologists PHILADELPHIA, Aug. 13, 2013 /PRNewswire/ -- GenoSpace, PathGroup and the IP & Science business of Thomson Reuters today announced an innovative initiative to develop and deliver a best-in-class personalized medicine service in oncology, the result of which will enable physicians to make more precise therapeutic recommendations for cancer patients....

2013-08-08 23:22:02

MarketResearch.com announces the addition of a new market research report in Diagnostics to their product offering: Personalized Medicine and Companion Diagnostic Market Q2 2013- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment (http://www.marketresearch.com/land/product.asp?productid=7690582&progid=85659). Rockville, MD (PRWEB) August 08, 2013 Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends,...

2013-08-08 16:26:48

Believed to be first clinical test to identify variants of four enzymes that mediate drug metabolism, providing greater insights for guiding treatment for the more than 100 million Americans with chronic pain MADISON, N.J., Aug. 8, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of a new lab-developed genetic test to aid the delivery of personalized opioid pain-relieving treatment....